Allergy Skin Prick And Intradermal Testing
BOOK AN APPOINTMENT About Us Allergy Skin Prick And Intradermal Testing Allergy skin testing is one of the most reliable methods used by allergists to identify what triggers a person’s allergic reactions. Two common techniques—skin prick testing and intradermal testing—help reveal sensitivities to airborne allergens, insect venom, or certain medications. These tests are essential in diagnosing allergic conditions accurately, allowing specialists to design personalized treatment plans. When performed correctly, allergy
Lifestyle Impact of Allergic Rhinitis: Symptoms & Relief
Lifestyle Impact of Allergic Rhinitis: Symptoms & Relief Allergic rhinitis (hay fever) often begins with sneezing or nasal congestion, but when left untreated, its effects extend far beyond the nose. Persistent symptoms can disrupt sleep, reduce productivity, affect emotional well-being, and even increase the risk of asthma complications. This guide explains how allergic rhinitis impacts daily life and the most effective ways to manage it. In This Guide What allergic
Adult Attention Deficit Hyperactivity Disorder (ADHD)
Understanding Adult ADHD: Signs, Symptoms & Daily Challenges Attention Deficit Hyperactivity Disorder (ADHD) is often associated with children, but for many people, the condition continues into adulthood. Adult ADHD can affect concentration, organization, productivity, relationships, and emotional well-being. Understanding how ADHD presents in adults is the first step toward recognizing the condition and seeking appropriate support. In This Guide What adult ADHD is Common signs and symptoms Different types of
Dupixent FDA Approval for Chronic Spontaneous Urticaria
Dupixent Gains FDA Approval for Chronic Spontaneous Urticaria: A New Era of Patient Relief The U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for the treatment of chronic spontaneous urticaria (CSU) in patients whose symptoms remain uncontrolled despite standard antihistamine therapy. This important milestone introduces a new targeted biologic treatment option for people living with chronic hives and persistent itching. Key Highlights FDA-approved for chronic spontaneous urticaria (CSU).
Andembry® Approved as a New Preventive Treatment for Hereditary Angioedema (HAE)
Andembry® Approved as a New Preventive Treatment for Hereditary Angioedema (HAE) The approval of Andembry® as a preventive treatment for hereditary angioedema (HAE) marks an important advancement in the management of this rare genetic condition. For patients living with unpredictable and potentially life-threatening swelling attacks, this targeted therapy offers a new option for long-term disease prevention and improved quality of life. Medical Update New preventive treatment approved for hereditary angioedema
Dupixent Gains Approval for Chronic Spontaneous Urticaria: A New Era of Relief for Patients
Dupixent Gains Approval for Chronic Spontaneous Urticaria: A New Era of Relief for Patients The approval of Dupixent® (dupilumab) for chronic spontaneous urticaria (CSU) marks an important advancement in the treatment of this challenging condition. For patients living with persistent hives, severe itching, and unpredictable flare-ups despite standard therapy, this targeted biologic treatment offers a promising new option for long-term symptom control and improved quality of life. Medical Update Dupixent®
Exdensur: New Asthma Treatment With Twice-Yearly Dosing
Exdensur: A New Asthma Treatment With Twice-Yearly Dosing Asthma affects millions of people worldwide, and for many patients, daily inhalers remain an essential part of treatment. However, remembering medications every day and maintaining proper inhaler technique can be challenging. Exdensur introduces a new approach to asthma management with twice-yearly dosing, offering eligible patients a convenient option for long-term disease control. Medical Update Innovative long-acting asthma therapy. Twice-yearly dosing schedule. Designed
How Air Quality Affects Allergy Patients
How Air Quality Affects Allergy Patients Air quality plays a major role in the health of people living with allergies and asthma. Pollutants such as pollen, dust, smoke, and airborne particles can worsen symptoms, trigger flare-ups, and affect overall quality of life. Understanding how air pollution interacts with allergic conditions can help patients reduce exposure and better manage their symptoms. Quick Guide Poor air quality can worsen allergy and asthma
Seasonal Allergies: Causes, Symptoms & Prevention
Seasonal Allergies: Causes, Symptoms & Prevention Seasonal allergies, also known as hay fever or seasonal allergic rhinitis, affect millions of people every year. While blooming trees, fresh-cut grass, and changing seasons are part of nature, they can also release airborne allergens that trigger sneezing, congestion, itchy eyes, and other uncomfortable symptoms. Understanding what causes seasonal allergies—and how to prevent them—can help you stay healthier throughout allergy season. Quick Guide Pollen
Ragweed Season Is Here: Why Fall Allergies Spike Every Year
Ragweed Season Is Here: Why Fall Allergies Spike Every Year As summer comes to an end, many people begin experiencing sneezing, nasal congestion, itchy eyes, and other allergy symptoms. One of the biggest reasons is ragweed pollen—a common fall allergen capable of traveling for miles through the air. Understanding why ragweed season causes such intense allergy symptoms can help you prepare and reduce its impact on your daily life. Quick
Santa Ana Winds & Allergy Flares – Dr. Ahdad Ziyar
Santa Ana Winds & Allergy Flares: What You Need to Know Southern California’s Santa Ana winds are well known for their warm, dry conditions, but they also create difficult environments for people living with allergies and asthma. These powerful winds can carry pollen, dust, mold spores, and even wildfire smoke across long distances, leading to allergy flare-ups and respiratory irritation. Understanding how Santa Ana winds affect your health can help
Nemluvio: Targeting the Underlying Itch to Treat Eczema and Prurigo Nodularis
Nemluvio: Targeting the Underlying Itch to Treat Eczema and Prurigo Nodularis Chronic inflammatory skin conditions such as eczema (atopic dermatitis) and prurigo nodularis are often driven by one of their most challenging symptoms—persistent, severe itching. More than simple discomfort, chronic itch can interfere with sleep, daily activities, emotional well-being, and overall quality of life. Nemluvio is a targeted therapy designed to address the biological pathways responsible for chronic itch, offering
ANZUPGO: The First FDA-Approved Treatment for Chronic Hand Eczema
ANZUPGO: The First FDA-Approved Treatment for Chronic Hand Eczema Chronic hand eczema (CHE) is a persistent inflammatory skin condition that can make everyday activities painful and frustrating. Cracked skin, redness, itching, and recurring flare-ups often interfere with work, household tasks, and overall quality of life. ANZUPGO® (delgocitinib) is the first FDA-approved treatment developed specifically for adults with chronic hand eczema whose symptoms remain uncontrolled despite standard topical therapies. Medical Update
RHAPSIDO: The First FDA-Approved Oral targeted treatment for Chronic Spontaneous Urticaria
RHAPSIDO: The First FDA-Approved Oral Targeted Treatment for Chronic Spontaneous Urticaria Chronic spontaneous urticaria (CSU) can be frustrating for patients who continue to experience persistent hives and itching despite taking antihistamines. RHAPSIDO® (remibrutinib) is the first FDA-approved oral targeted therapy developed specifically for adults with CSU that remains uncontrolled with standard treatment. This approval introduces a convenient pill-based option that targets the underlying immune pathways involved in chronic hives. Medical